It"s uncommon for a high-powered CEO to step aside at the age of 55, and observers have a right to be skeptical about the reasons for his departure. Ebright, though, insists he will continue to head Cytogen"s board and be around "to assure the succession plan." He also plans to devote time to his farm in Maryland and says he "might very well surface somewhere and be active in the health-care business."